File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Bioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway

TitleBioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway
Authors
KeywordsAnti-inflammation
Bioassay-guided fractionation
Cyclooxygenase-2
Inducible nitric oxide synthase
Interleukin-6
Nitric oxide
Prostaglandin E2
Rehmannia glutinosa
Rehmapicrogenin
Issue Date2012
Citation
Journal of Ethnopharmacology, 2012, v. 143, n. 3, p. 867-875 How to Cite?
AbstractEthnopharmacological relevance: The root of Rehmannia glutinosa (RR) is commonly used to reduce inflammation in various traditional Chinese herbal formulae; however, little is known regarding its active component(s). Aim of study: The objective of the present study was to examine the active component(s) responsible for the anti-inflammatory activity of RR via anti-nitric oxide production assay-guided fractionation; and the underlying anti-inflammatory mechanism of action of such component(s) was further investigated. Materials and methods: Anti-nitric oxide (NO) activities with lipopolysaccharides (LPS)-stimulated RAW264.7 murine macrophages was used as screening platform. Gene, protein and inflammatory mediators' expression were also studied using real-time PCR, western blotting and ELISA, respectively. Results: Using anti-NO assay-guided fractionation, sub-fraction C3 (from 31.25 to 62.5 μg/ml, p=0.001 to 0.01) possessed 100-fold more potent anti-inflammatory effect than that of the aqueous extract of RR. Characterization of C3 showed that the anti-inflammatory effect could be partly due to the presence of rehmapicrogenin, which could significantly inhibit NO production (p<0.001). C3 was further demonstrated in blocking inflammation by inhibiting gene (p<0.001) and protein expression of inducible NO synthase (iNOS) dose-dependently. Besides, C3 also significantly inhibited the production of prostaglandin E2 (p<0.001 to 0.01), IL-6 (p<0.001 to 0.05) and COX-2 (p<0.05). Conclusions: Rehmapicrogenin was, for the first time, shown to possess nitric oxide inhibitory activities. Bioassay-guided fractionation demonstrated that rehmapicrogenin-containing subfraction C3 exhibited potent anti-inflammatory effect by inhibiting iNOS, COX-2 and IL-6, while rehmapicrogenin was only partially responsible for the anti-inflammatory effect of RR. © 2012 Elsevier Ireland Ltd. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/343105
ISSN
2023 Impact Factor: 4.8
2023 SCImago Journal Rankings: 0.936

 

DC FieldValueLanguage
dc.contributor.authorLiu, Cheuk Lun-
dc.contributor.authorCheng, Ling-
dc.contributor.authorKo, Chun Hay-
dc.contributor.authorWong, Chun Wai-
dc.contributor.authorCheng, Wai Hing-
dc.contributor.authorCheung, David Wing Shing-
dc.contributor.authorLeung, Ping Chung-
dc.contributor.authorFung, Kwok Pui-
dc.contributor.authorBik-San Lau, Clara-
dc.date.accessioned2024-05-10T09:05:28Z-
dc.date.available2024-05-10T09:05:28Z-
dc.date.issued2012-
dc.identifier.citationJournal of Ethnopharmacology, 2012, v. 143, n. 3, p. 867-875-
dc.identifier.issn0378-8741-
dc.identifier.urihttp://hdl.handle.net/10722/343105-
dc.description.abstractEthnopharmacological relevance: The root of Rehmannia glutinosa (RR) is commonly used to reduce inflammation in various traditional Chinese herbal formulae; however, little is known regarding its active component(s). Aim of study: The objective of the present study was to examine the active component(s) responsible for the anti-inflammatory activity of RR via anti-nitric oxide production assay-guided fractionation; and the underlying anti-inflammatory mechanism of action of such component(s) was further investigated. Materials and methods: Anti-nitric oxide (NO) activities with lipopolysaccharides (LPS)-stimulated RAW264.7 murine macrophages was used as screening platform. Gene, protein and inflammatory mediators' expression were also studied using real-time PCR, western blotting and ELISA, respectively. Results: Using anti-NO assay-guided fractionation, sub-fraction C3 (from 31.25 to 62.5 μg/ml, p=0.001 to 0.01) possessed 100-fold more potent anti-inflammatory effect than that of the aqueous extract of RR. Characterization of C3 showed that the anti-inflammatory effect could be partly due to the presence of rehmapicrogenin, which could significantly inhibit NO production (p<0.001). C3 was further demonstrated in blocking inflammation by inhibiting gene (p<0.001) and protein expression of inducible NO synthase (iNOS) dose-dependently. Besides, C3 also significantly inhibited the production of prostaglandin E2 (p<0.001 to 0.01), IL-6 (p<0.001 to 0.05) and COX-2 (p<0.05). Conclusions: Rehmapicrogenin was, for the first time, shown to possess nitric oxide inhibitory activities. Bioassay-guided fractionation demonstrated that rehmapicrogenin-containing subfraction C3 exhibited potent anti-inflammatory effect by inhibiting iNOS, COX-2 and IL-6, while rehmapicrogenin was only partially responsible for the anti-inflammatory effect of RR. © 2012 Elsevier Ireland Ltd. All rights reserved.-
dc.languageeng-
dc.relation.ispartofJournal of Ethnopharmacology-
dc.subjectAnti-inflammation-
dc.subjectBioassay-guided fractionation-
dc.subjectCyclooxygenase-2-
dc.subjectInducible nitric oxide synthase-
dc.subjectInterleukin-6-
dc.subjectNitric oxide-
dc.subjectProstaglandin E2-
dc.subjectRehmannia glutinosa-
dc.subjectRehmapicrogenin-
dc.titleBioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.jep.2012.08.012-
dc.identifier.pmid23034094-
dc.identifier.scopuseid_2-s2.0-84866737060-
dc.identifier.volume143-
dc.identifier.issue3-
dc.identifier.spage867-
dc.identifier.epage875-
dc.identifier.eissn1872-7573-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats